India IVF market seen reaching $4.6B by 2032

By AI, Created 8:50 AM UTC, May 25, 2026, /AGP/ – Allied Market Research projects India’s in-vitro fertilization services market will grow from $0.8 billion in 2022 to $4.6 billion by 2032, driven by rising infertility, late pregnancies and IVF technology gains. The report points to higher demand for fertility clinics, but says treatment cost remains a key restraint.

Why it matters: - India’s IVF services market is on track for rapid expansion, signaling stronger demand for fertility care across clinics, hospitals and related service providers. - The projected growth reflects wider access to assisted reproductive technology as infertility rates rise and treatment outcomes improve. - The report says the market could become a bigger commercial opportunity for fertility chains, drug makers and IVF service providers over the next decade.

What happened: - Allied Market Research released a report on the India in-vitro fertilization services market on May 25, 2026. - The report values the market at $0.8 billion in 2022 and projects it will reach $4.6 billion by 2032. - The forecast implies a compound annual growth rate of 18.08% from 2023 to 2032. - The report covers market segments by gender, procedure, cycle type, end user and offering.

The details: - Rising infertility among men and women is one of the main growth drivers. - Late pregnancies are also boosting demand for IVF services. - Technological advances in assisted reproductive technology are supporting higher IVF success rates. - Higher disposable income in India is helping more patients access treatment. - The report also cites rising gamete donations as a growth driver. - The market segments studied include male infertility, female infertility and other categories. - Procedure segments include intracytoplasmic sperm injection IVF, non-ICSI IVF and intrauterine insemination. - Cycle types include fresh IVF cycles, thawed IVF cycles and donor egg IVF cycles. - End users include fertility clinics, hospitals, surgical centers and clinical research institutes. - Offerings include IVF drugs, IVF media and reagents, and IVF and IUI services. - The report lists major India IVF companies including ART Fertility Clinics, Nova IVI Fertility, Medicover and Prashanth Fertility Research Centre. - The report says the COVID-19 pandemic disrupted the market because of shutdowns and healthcare workers falling ill. - The report says the post-pandemic market is growing because infertility cases are increasing and more fertility clinics are opening. - High treatment cost remains a major restraint on market growth. - The report highlights growth opportunities in emerging markets.

Between the lines: - The forecast suggests IVF demand in India is shifting from a niche fertility option toward a broader healthcare category with expanding private-sector participation. - The combination of higher infertility rates and better technology points to a market driven by both medical need and improved affordability over time, even though cost still limits access. - The company’s company list and segment breakdown indicate a market that is becoming more organized and competitive.

What’s next: - The report expects continued growth through 2032 as more fertility clinics enter the market and IVF adoption rises. - The main near-term question is whether pricing pressure or better insurance and financing options can widen access enough to sustain the forecast. - Allied Market Research offers the sample report with graphs and figures and purchase inquiry pages for readers seeking more detail.

The bottom line: - India’s IVF market is projected to multiply nearly sixfold by 2032, with infertility growth and technology gains outweighing the drag from high treatment costs.